Skip to main content
Main navigation
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Main navigation
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Psychopharmacology
Assessing Anticholinergic Burden
Welcome to Schizophrenia Knowledge Base
This website is intended for healthcare professionals in the United States.
Yes, I am a US healthcare professional
No, I am not a US healthcare professional
CME: Emerging Therapeutic Targets for Schizophrenia: A Focus on Muscarinic Acetylcholine Receptor Activation
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms
CME: Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment
Muscarinic Pathways in Schizophrenia: Unlocking New Therapeutic Targets
CME: Meet Me at the Water Cooler: Schizophrenia
CME: End of the Anticholinergic Era? Challenging Cases in Anticholinergic Deprescribing: Real-World Scenarios (Module 4)
CME: End of the Anticholinergic Era? Deprescribing with Confidence: Strategies for Safe Medication Changes (Module 3)
CME: End of the Anticholinergic Era? Measuring the Impact: Understanding Anticholinergic Burden (Module 2)
CME: I Love Muscarinic Control! Targeting the Muscarinic System in the Treatment of Schizophrenia
CME: End of the Anticholinergic Era? Breaking Down the Anticholinergic System: Risks and Realities (Module 1)
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Current page
2
Page
3
Page
4
Next page
Next ›
Last page
Last »